(-)-Epigallocatechin gallate inhibits basic fibroblast growth factor-stimulated interleukin-6 synthesis in osteoblasts

Hormone and Metabolic Research

Volumn 40, Issue 10, 2008, Pages 674-678

  Tokuda, H ^a,b   Takai, S ^b   Hanai, Y ^a,b   Matsushima Nishiwaki, R ^b   Yamauchi, J ^b   Harada, A ^a   Hosoi, T ^a   Ohta, T ^a   Kozawa, O ^b  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Basic fibroblast growth; Catechin; Factor; Interleukin 6; MAP kinase; Osteoblast

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BASIC FIBROBLAST GROWTH FACTOR; EPIGALLOCATECHIN GALLATE; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYNTHESIS;

ANIMALS; ANTHRACENES; CATECHIN; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN-6; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; ORGANIC CHEMICALS; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION;

EID: 54049095225     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1073164     Document Type: Article

References (28)

1. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 1997; 387: 561
2. Harbourne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry 2000; 55: 481-504
3. Nijweide PJ, Burger EH, Feyen JHM. Cells of bone: proliferation, differentiation, and humoral regulation. Physiol Rev 1986; 66: 855-886
4. Delaisse JM, Eeckhout Y, Vaes G. Inhibition of bone resorption in culture by (+)-catechin. Biochem Pharmacol 1986; 35: 3091-3094
5. Choi E-M, Hwang J-K. Effects of (+)-catechin on the function of osteoblastic cells. Biol Pharm Bull 2003; 26: 523-526
6. Vali B, Rao LG, El-Sohemy A. Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem 2007; 18: 341-347
7. 2α-induced VEGF synthesis via up-regulating SAPK/JNK activation in osteoblasts. J Cell Biochem 2007; 100: 1146-1153
8. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993; 54: 1-78
9. Heymann D, Rousselle AV. gp130 Cytokine family and bone cells. Cytokine 2000; 12: 1455-1468
10. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, FGF-2-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004; 15: 49-60
11. Blair HC, Robinson LJ, Zaidi M. Osteoclast signalling pathways. Biochem Biophys Res Commun 2005; 328: 728-738
12. Ishimi T, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi Y, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990; 145: 3297-3303
13. Helle M, Brakenhoff JPJ, Groot ER De, Aarden LA. Interleukin-6 is involved in interleukin-1-induced activities. Eur J Immunol 1988; 18: 957-959
14. Littlewood AJ, Russil J, Harvey GR, Hughes DE, Russel RGG, Gowen M. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology 1991; 129: 1513-1520
15. Roodman GD. Interleukin-6: an osteotropic factor? J Bone Miner Res 1992; 7: 475-478
16. Kozawa O, Tokuda H, Matsuno H, Uematsu T. Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts. J Cell Biochem 1999; 74: 479-485
17. Kyriakis JM, Avruch J. Mammarian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807-869
18. Sudo H, Kodama H, Amagai Y, Yamamoto S, Kasai S. In vivo differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983; 96: 191-198
19. 2α stimulates interleukin-6 via activation of PKC in osteoblast-like cells. Am J Physiol 1997; 272: E208-E211
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
21. Kato K, Ito H, Hasegawa K, Inaguma Y, Kozawa O, Asano T. Modulation of the stress-induced synthesis of hsp27 and αB-crystallin by cyclic AMP in C6 glioma cells. J Neurochem 1996; 66: 946-950
22. Tokuda H, Kozawa O, Uematsu T. Basic fibroblast growth factor stimulates vascular endothelial growth factor synthesis in osteoblasts: divergent regulation by p42/p44 MAP kinase and p38 MAP kinase. J Bone Miner Res 2000; 15: 2371-2379
23. Tokuda H, Hirade K, Wang X, Oiso Y, Kozawa O. Involvement of SAPK/JNK in basic fibroblast growth factor-induced VEGF release in osteoblasts. J Endocrinol 2003; 177: 101-107
24. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 1995; 270: 27489-27494
25. Bennett BL, Sasaki DT, Murray BW, Oleary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001: 98: 13681-13686
26. Tokuda H, Takai S, Hanai Y, Matsushima-Nishiwaki R, Hosoi T, Harada A, Ohta T, Kozawa O. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: Inhibition of p44/p42 MAP kinase activation. FEBS Lett 2007; 581: 1311-1316
27. Nakagawa H, Wachi M, Woo JT, Kato M, Kasai S, Takahashi F, Lee IS, Nagai K. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun 2002; 292: 94-101
28. Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Kichard-Caudron AS, Pinceau B, Weber P. A single ascending dose study of epigalocatechin gallate in healthy volunteers. J Int Med Res 2003; 31: 88-101